Two patients withTorulopsis glabratafungemia were cured. One, an elderly man with cancer, diabetes, andPseudomonasurinary tract infection, had received many antibiotics. His cure was attributed to amphotericin B therapy. The other patient was pregnant, and the source of the fungemia was never detected; her cure was associated with the termination of pregnancy. With this method of laboratory identification ofT glabrataand increased awareness of the potential pathogenicity of the so-called opportunistic fungi on the part of both the clinical microbiologist and the clinician, more cases ofT glabratainfection will be recognized, particularly among patients who are debilitated or who have altered host defenses.